Tellgen Corporation Secures Six New Medical Device Approvals
Stock News
Yesterday
Tellgen Corporation (300642.SZ) has announced that the company and its controlling subsidiary, Shanghai Maishi Biotechnology Co., Ltd., recently obtained six medical device registration certificates issued by the Shanghai Municipal Drug Administration.
These newly acquired certifications expand the company's product line across multiple technology platforms and further strengthen its business layout in the non-tumor diagnostic segment. The approvals are expected to enhance the overall brand influence and market expansion capabilities of the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.